Internal Medicine Acronyms

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Internal Medicine Alphabet – X

S. No	Acronyms	Full Form	Short Explanation	Practical Example
X001	XAI	Explainable Artificial Intelligence	AI model that provides understandable outputs	XAI used in predictive healthcare diagnostics
X002	XAL	Xenon Anesthetic Level	Concentration of xenon in anesthesia	XAL monitored during surgery
X003	XBP	X-Box Protein	Protein involved in cellular stress response	XBP measured in ER stress research
X004	XCL	Chemokine Ligand X	Chemokine signaling molecule	XCL studied in immunology research
X005	XDR	Extensively Drug-Resistant	Resistant to multiple antibiotic classes	XDR-TB treated in specialized centers
X006	XGP	Xanthogranulomatous Pyelonephritis	Chronic kidney infection	XGP diagnosed on CT scan
X007	XG	Xerostomia Grading	Salivary gland dysfunction scale	XG used in radiation therapy follow-up
X008	XH	Xenobiotic Hepatotoxicity	Liver damage from foreign compounds	XH monitored in drug trials
X009	XI	Extraintestinal Infection	Infection outside the gut	XI seen in Crohn’s disease complication
X010	XL	X-Linked	Genetic inheritance on X chromosome	XL agammaglobulinemia diagnosed in males
X011	XLA	X-Linked Agammaglobulinemia	Immunodeficiency disease	XLA treated with IVIG therapy
X012	XM	Xanthoma Marker	Lipid deposit indicator	XM observed in hyperlipidemia patients
X013	XMC	Xanthomatosis Cerebral	Rare lipid deposition in brain	XMC diagnosed with MRI
X014	XN	Xanthochromia	Yellow cerebrospinal fluid	XN indicates subarachnoid hemorrhage
X015	XNS	Xenon Nuclear Scan	Imaging technique	XNS performed in cardiac perfusion study
X016	XO	Xanthine Oxidase	Enzyme producing uric acid	XO inhibitors used in gout treatment
X017	XOD	Xanthine Oxidase Deficiency	Genetic enzyme deficiency	XOD diagnosed in metabolic disorder
X018	XPA	Xeroderma Pigmentosum Group A	DNA repair disorder	XPA managed with UV protection
X019	XPB	Xeroderma Pigmentosum Group B	DNA repair disorder	XPB monitored for skin cancer risk
X020	XPC	Xeroderma Pigmentosum Group C	DNA repair disorder	XPC genetic testing performed
X021	XPD	Xeroderma Pigmentosum Group D	DNA repair disorder	XPD patients avoid UV exposure
X022	XPE	Xeroderma Pigmentosum Group E	DNA repair disorder	XPE diagnosed in childhood
X023	XPF	Xeroderma Pigmentosum Group F	DNA repair disorder	XPF mutation confirmed by genetic testing
X024	XPG	Xeroderma Pigmentosum Group G	DNA repair disorder	XPG mutation monitored for cancer risk
X025	XQ	Xenograft Quality	Assessment of transplanted tissue	XQ measured in preclinical studies
X026	XR	X-Ray	Imaging modality	XR used to detect bone fractures
X027	XRA	X-Ray Absorptiometry	Bone density measurement	XRA used in osteoporosis evaluation
X028	XRC	X-Ray Computed	Imaging method	XRC performed for chest evaluation
X029	XRF	X-Ray Fluorescence	Elemental analysis technique	XRF used in toxicology testing
X030	XRT	X-Ray Therapy	Radiation treatment	XRT used in oncology for tumor control

S. No	Acronyms	Full Form	Short Explanation	Practical Example
X031	XRT	External Radiation Therapy	Radiation treatment for cancer	XRT applied in breast cancer management
X032	XSA	Xanthine Serum Analysis	Lab test for uric acid metabolism	XSA used in gout evaluation
X033	XSG	X-Linked Severe Combined Immunodeficiency	Genetic immunodeficiency	XSG treated with stem cell transplantation
X034	XSL	X-Linked Lymphoproliferative Disease	Genetic immune disorder	XSL diagnosed in childhood
X035	XSM	Xanthoma Spread Measurement	Lipid deposit assessment	XSM measured in hyperlipidemia patients
X036	XSN	X-Syndrome Neuropathy	Rare neurological disorder	XSN monitored in neurology clinic
X037	XSP	Xenograft Survival Percentage	Measure of transplant success	XSP calculated in experimental studies
X038	XST	X-Linked Severe Thrombocytopenia	Genetic platelet disorder	XST treated with platelet transfusions
X039	XSV	Xenograft Survival Verification	Tissue transplant assessment	XSV used in preclinical trials
X040	XTB	X-Linked Tubulopathy	Genetic kidney disorder	XTB managed with electrolyte monitoring
X041	XTC	X-Linked T-Cell Deficiency	Immune disorder	XTC diagnosed in infancy
X042	XTF	Xanthomatosis Test Fraction	Lab assessment	XTF measured in lipid disorder workup
X043	XTG	Xanthogranulomatous Gastritis	Rare gastric inflammation	XTG confirmed via biopsy
X044	XTH	Xanthomatosis Therapy	Treatment for lipid deposition	XTH includes statin therapy
X045	XTI	X-Linked Thrombocytopenia Inheritance	Genetic platelet disorder	XTI evaluated in family screening
X046	XTM	Xanthoma Marker	Lab marker for lipid deposits	XTM elevated in hyperlipidemia
X047	XTN	Xanthine Nephropathy	Kidney damage from uric acid	XTN managed with hydration and allopurinol
X048	XTO	Xenobiotic Toxicity Observation	Drug safety evaluation	XTO assessed during clinical trials
X049	XTP	X-Linked Thrombocytopenia Platelets	Low platelet count	XTP treated with transfusions
X050	XTR	X-Ray Tomography Reconstruction	Imaging processing technique	XTR used in CT scan analysis
X051	XTS	X-Linked Thrombocytopenia Syndrome	Genetic platelet disorder	XTS monitored in hematology clinic
X052	XTU	Xanthine Tubulopathy	Kidney damage from xanthine	XTU treated with allopurinol
X053	XV	X-Ray Ventilation Study	Lung imaging technique	XV performed to evaluate pulmonary embolism
X054	XVA	Xenograft Vascular Assessment	Blood flow evaluation	XVA used in transplant research
X055	XVG	Xenobiotic Volume of Distribution	Pharmacokinetic parameter	XVG calculated during drug studies
X056	XVL	X-Ray Vertebral Level	Spinal imaging reference	XVL used in spine radiography
X057	XVM	Xenograft Viability Measurement	Transplant tissue assessment	XVM performed post-transplantation
X058	XVN	Xenograft Vessel Network	Blood vessels in transplanted tissue	XVN visualized via angiography
X059	XVP	Xanthine Valvular Pathology	Lipid-related heart valve disorder	XVP observed in echocardiography
X060	XVQ	Xanthoma Volume Quantification	Measure of lipid deposits	XVQ assessed via MRI
X061	XVR	X-Ray Ventricular Response	Cardiac imaging measure	XVR evaluated during stress testing
X062	XVS	Xanthoma Vascular Screening	Assessment of vascular lipid deposits	XVS performed in cardiovascular clinic
X063	XVT	Xanthoma Volume Tracking	Monitoring lipid deposition	XVT used during treatment follow-up
X064	XVW	X-Ray View Window	Imaging technique parameter	XVW adjusted in radiology settings
X065	XX	Double X Chromosome	Female karyotype	XX genotype confirmed in genetics testing
X066	XXX	Triple X Syndrome	Extra X chromosome in females	XXX syndrome monitored for developmental delays
X067	XXY	Klinefelter Syndrome	Extra X in males	XXY diagnosed via karyotype
X068	XXZ	Experimental Xenobiotic Zone	Research area for drug testing	XXZ studied in pharmacology lab
X069	XY	Male Karyotype	Single X and Y chromosomes	XY confirmed in genetic testing
X070	XYY	Jacob’s Syndrome	Extra Y chromosome in males	XYY diagnosed in growth disorder evaluation
X071	XYZ	Miscellaneous Experimental Variable	Research term	XYZ used in clinical trial data
X072	XZ	Xylazine	Sedative and analgesic	XZ used in veterinary medicine
X073	XZA	Xylazine Analgesia	Pain relief using xylazine	XZA applied in animal anesthesia
X074	XZB	Xylazine Biomarker	Marker for drug monitoring	XZB measured in pharmacokinetic studies
X075	XZC	Xylazine Clearance	Drug elimination rate	XZC calculated in lab tests
X076	XZD	Xylazine Dose	Administered drug quantity	XZD adjusted for animal weight
X077	XZE	Xylazine Effect	Pharmacologic response	XZE observed in sedated subjects
X078	XZF	Xylazine Formulation	Drug preparation type	XZF chosen for injection
X079	XZG	Xylazine Gastrointestinal Effect	Drug impact on GI system	XZG monitored in research animals
X080	XZH	Xylazine Hemodynamic Effect	Blood pressure and heart rate impact	XZH tracked during anesthesia
X081	XZI	Xylazine Induced Sedation	Sedative outcome	XZI measured in animal study
X082	XZJ	Xylazine Joint Effect	Effect on joints	XZJ monitored in veterinary studies
X083	XZK	Xylazine Kidney Impact	Renal effect of drug	XZK monitored in lab animals
X084	XZL	Xylazine Liver Effect	Hepatic impact	XZL tracked in toxicity study
X085	XZM	Xylazine Metabolism	Drug biotransformation	XZM analyzed in pharmacokinetics
X086	XZN	Xylazine Neurologic Effect	CNS effect	XZN observed in animal sedation study
X087	XZO	Xylazine Oxygenation Effect	Impact on blood oxygen	XZO monitored during anesthesia
X088	XZP	Xylazine Pulmonary Effect	Lung function impact	XZP measured in lab studies
X089	XZQ	Xylazine Quality Control	Drug quality assessment	XZQ verified in lab
X090	XZR	Xylazine Respiratory Effect	Impact on breathing	XZR observed in sedated subjects
X091	XZS	Xylazine Sedation Score	Level of sedation	XZS recorded during experiments
X092	XZT	Xylazine Toxicity	Adverse effects	XZT evaluated in animal study
X093	XZU	Xylazine Usage	Drug administration	XZU documented in lab protocol
X094	XZV	Xylazine Vascular Effect	Blood vessel response	XZV measured in pharmacology study
X095	XZW	Xylazine Withdrawal	Drug discontinuation effect	XZW monitored in research
X096	XZX	Xylazine Experimental Dose	Research drug level	XZX used in animal study
X097	XZY	Xylazine Yield	Drug efficacy measurement	XZY calculated in lab trial
X098	XZZ	Xylazine Z-Score	Statistical measure of effect	XZZ used in pharmacology analysis
X099	XAA	Xenograft Analysis Assay	Tissue evaluation test	XAA used in transplant research
X100	XAB	Xenobiotic Absorption	Drug uptake in body	XAB measured in pharmacokinetics

S. No	Acronyms	Full Form	Short Explanation	Practical Example
X101	XAC	Xenobiotic Clearance	Rate at which foreign compounds are removed	XAC measured in drug metabolism studies
X102	XAD	Xenobiotic Distribution	How drugs distribute in body tissues	XAD analyzed in pharmacokinetics
X103	XAE	Xenograft Effectiveness	Success of transplanted tissue	XAE monitored in preclinical trials
X104	XAF	Xanthine Assessment Fraction	Lab evaluation for uric acid metabolism	XAF used in gout assessment
X105	XAG	Xanthogranuloma	Benign lipid-rich lesion	XAG diagnosed on skin biopsy
X106	XAH	Xenobiotic Hepatotoxicity	Liver damage due to foreign compounds	XAH monitored in drug trials
X107	XAI	Explainable Artificial Intelligence	AI providing understandable outputs	XAI used in diagnostic imaging
X108	XAJ	Xenobiotic Analysis Journal	Scientific literature source	XAJ referenced in pharmacology research
X109	XAK	Xanthine Kidney Effect	Kidney impact of xanthine	XAK monitored in metabolic disorder
X110	XAL	Xenon Anesthetic Level	Anesthetic concentration of xenon	XAL monitored in surgery
X111	XAM	Xenobiotic Absorption Measurement	Drug uptake testing	XAM used in pharmacology studies
X112	XAN	Xanthoma	Lipid-rich skin lesion	XAN observed in hyperlipidemia
X113	XAO	Xanthine Oxidase Overactivity	Enzyme producing excess uric acid	XAO treated with allopurinol
X114	XAP	Xanthine Assessment Panel	Lab tests for xanthine metabolism	XAP performed for metabolic workup
X115	XAQ	Xenograft Quality	Tissue transplant assessment	XAQ monitored in preclinical study
X116	XAR	Xanthine-Related Renal Damage	Kidney injury due to xanthine	XAR treated with hydration
X117	XAS	Xanthogranulomatous Appendicitis	Rare appendix inflammation	XAS diagnosed on histopathology
X118	XAT	Xenobiotic Toxicity	Harmful effects of foreign substances	XAT evaluated in clinical trials
X119	XAU	Xanthine Urinary Excretion	Uric acid in urine	XAU measured in metabolic disorders
X120	XAV	Xenograft Vascularization	Blood vessel development in transplant	XAV monitored post-transplant
X121	XAW	Xanthoma Weight	Size of lipid deposit	XAW measured in dermatology
X122	XAX	Xenobiotic Assay	Test for foreign compound detection	XAX performed in pharmacology lab
X123	XAY	Xenobiotic Yield	Drug metabolism efficiency	XAY measured in pharmacokinetic study
X124	XAZ	Xanthogranulomatous Zygoma Lesion	Rare facial lesion	XAZ treated surgically
X125	XBA	Xenobiotic Blood Analysis	Drug levels in blood	XBA measured in toxicology
X126	XBB	Xanthogranulomatous Biliary Disease	Rare bile duct condition	XBB confirmed with imaging
X127	XBC	Xanthogranulomatous Cholecystitis	Chronic gallbladder inflammation	XBC diagnosed on ultrasound
X128	XBD	Xenograft Biopsy Determination	Tissue sampling	XBD performed post-transplant
X129	XBE	Xanthine Blood Enzyme	Enzyme measurement	XBE measured in metabolic disorder
X130	XBF	Xanthine Blood Fraction	Lab test for uric acid	XBF measured in gout evaluation
X131	XBG	Xanthogranulomatous Gastritis	Rare gastric inflammation	XBG confirmed via endoscopy
X132	XBH	Xenobiotic Hepatic Function	Liver evaluation	XBH monitored in drug trials
X133	XBI	Xenograft Biopsy Imaging	Imaging of transplant tissue	XBI performed in research study
X134	XBJ	Xenobiotic Journal	Research source	XBJ referenced in pharmacology
X135	XBK	Xanthine Kidney Assessment	Kidney function test	XBK measured in metabolic disorders
X136	XBL	Xanthogranulomatous Lesion	Rare tissue lesion	XBL treated surgically
X137	XBM	Xenobiotic Metabolism	Drug breakdown in body	XBM measured in pharmacokinetics
X138	XBN	Xenobiotic Nephrotoxicity	Kidney injury due to drugs	XBN monitored in clinical trial
X139	XBO	Xenograft Observation	Monitoring transplant tissue	XBO performed post-op
X140	XBP	X-Box Protein	Protein in stress response	XBP measured in cell research
X141	XBQ	Xenobiotic Quantification	Measuring drug levels	XBQ used in lab tests
X142	XBR	Xanthine Blood Reduction	Lowering uric acid levels	XBR achieved with allopurinol
X143	XBS	Xenograft Blood Supply	Transplant tissue perfusion	XBS assessed in research study
X144	XBT	Xenobiotic Toxicology	Study of drug toxicity	XBT performed in preclinical studies
X145	XBU	Xenobiotic Urinary Excretion	Drug elimination via urine	XBU measured in pharmacokinetics
X146	XBV	Xenograft Blood Vessels	Vascularization in tissue	XBV visualized via imaging
X147	XBW	Xanthogranulomatous Weight	Mass of lesion	XBW measured in dermatology
X148	XBX	Xenobiotic Experimental Study	Lab drug testing	XBX performed in research lab
X149	XBY	Xenobiotic Yield Assessment	Efficiency of drug metabolism	XBY calculated in lab
X150	XBZ	Xenograft Zygosity	Genetic makeup of transplant tissue	XBZ confirmed via DNA testing
X151	XCA	Xanthine Clearance Assessment	Lab test for uric acid metabolism	XCA measured in gout evaluation
X152	XCB	Xenobiotic Blood Biochemistry	Lab measurement of drug effects	XCB monitored in trials
X153	XCC	Xenograft Cellular Count	Cell count in transplanted tissue	XCC assessed post-transplant
X154	XCD	Xanthogranulomatous Cholecystectomy	Surgical removal of gallbladder lesion	XCD performed in surgery
X155	XCE	Xenobiotic Clinical Evaluation	Drug safety assessment	XCE performed in trial
X156	XCF	Xanthine Clearance Fraction	Kidney function measure	XCF monitored in metabolic disorder
X157	XCG	Xenograft Growth	Tissue proliferation post-transplant	XCG monitored via imaging
X158	XCH	Xanthogranulomatous Hepatitis	Rare liver inflammation	XCH diagnosed via biopsy
X159	XCI	X-Chromosome Inactivation	Genetic phenomenon	XCI studied in genetics research
X160	XCJ	Xenobiotic Clinical Journal	Scientific literature	XCJ referenced in studies
X161	XCK	Xanthine Kinase	Enzyme in purine metabolism	XCK measured in lab tests
X162	XCL	Xenobiotic Clearance Level	Lab measurement of drug elimination	XCL monitored in pharmacokinetics
X163	XCM	Xenograft Cell Morphology	Tissue evaluation	XCM performed in pathology lab
X164	XCN	Xenobiotic Nephropathy	Kidney damage due to drugs	XCN treated with supportive care
X165	XCO	Xanthogranulomatous Oophoritis	Rare ovarian inflammation	XCO diagnosed via ultrasound
X166	XCP	Xenograft Cell Proliferation	Tissue growth measure	XCP monitored in research
X167	XCQ	Xenobiotic Quantification	Measuring drug levels	XCQ used in clinical trial
X168	XCR	Xenograft Cell Recovery	Tissue regeneration	XCR monitored post-transplant
X169	XCS	Xanthogranulomatous Sialadenitis	Rare salivary gland inflammation	XCS diagnosed with biopsy
X170	XCT	X-Ray Computed Tomography	Imaging technique	XCT performed for chest evaluation
X171	XCU	Xenobiotic Urine Analysis	Drug excretion assessment	XCU measured in trials
X172	XCV	Xenograft Cell Viability	Tissue health assessment	XCV monitored in lab study
X173	XCW	Xanthogranulomatous Weight	Mass of lesion	XCW measured in pathology
X174	XCX	Xenobiotic Experimental Study	Lab research term	XCX applied in pharmacology
X175	XCY	Xenobiotic Yield	Drug metabolism efficiency	XCY measured in pharmacokinetics
X176	XCZ	Xenograft Zygosity	Genetic assessment of tissue	XCZ confirmed in lab
X177	XDA	X-Ray Density Assessment	Imaging evaluation	XDA performed in radiology
X178	XDB	Xanthogranulomatous Disease Biopsy	Tissue sampling	XDB performed for diagnosis
X179	XDC	Xenobiotic Drug Clearance	Rate of drug elimination	XDC measured in trials
X180	XDD	Xanthogranulomatous Disease Diagnosis	Lab or imaging confirmation	XDD confirmed via biopsy
X181	XDE	Xenobiotic Drug Effect	Pharmacological response	XDE monitored in research
X182	XDF	Xanthogranulomatous Disease Fraction	Lab assessment	XDF measured in studies
X183	XDG	Xenobiotic Drug Growth	Effect on cell proliferation	XDG studied in vitro
X184	XDH	Xanthine Dehydrogenase	Enzyme in purine metabolism	XDH measured in lab
X185	XDI	Xenobiotic Drug Interaction	Drug-drug interactions	XDI evaluated in pharmacology
X186	XDJ	Xenograft Drug Journal	Research source	XDJ referenced in transplant studies
X187	XDK	Xenobiotic Drug Kinetics	Drug movement through body	XDK analyzed in trials
X188	XDL	Xanthogranulomatous Disease Lab	Lab testing	XDL performed for diagnosis
X189	XDM	Xenobiotic Dose Monitoring	Drug dose tracking	XDM measured in clinical trials
X190	XDN	Xenobiotic Drug Nephrotoxicity	Kidney toxicity from drugs	XDN monitored in trial
X191	XDO	Xenograft Drug Observation	Monitoring treatment effect	XDO performed in research
X192	XDP	Xanthogranulomatous Disease Pathology	Tissue pathology	XDP confirmed via biopsy
X193	XDQ	Xenobiotic Drug Quantification	Measuring drug levels	XDQ used in lab studies
X194	XDR	Extensively Drug-Resistant	Resistant to multiple drugs	XDR-TB managed with special antibiotics
X195	XDS	Xenobiotic Drug Safety	Drug safety evaluation	XDS assessed in clinical trial
X196	XDT	Xenobiotic Drug Toxicity	Adverse effects assessment	XDT monitored in research
X197	XDU	Xenobiotic Drug Urine	Drug levels in urine	XDU measured in trials
X198	XDV	Xenobiotic Drug Volume	Distribution measurement	XDV calculated in pharmacokinetics
X199	XDW	Xenobiotic Drug Withdrawal	Effects after stopping drug	XDW monitored in study
X200	XDX	Xenobiotic Drug Experiment	Research study on drug	XDX performed in lab